These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The absolute CBF response to activation is preserved during elevated perfusion: Implications for neurovascular coupling measures. Whittaker JR; Driver ID; Bright MG; Murphy K Neuroimage; 2016 Jan; 125():198-207. PubMed ID: 26477657 [TBL] [Abstract][Full Text] [Related]
3. Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience. Wu J; Dehkharghani S; Nahab F; Qiu D Neuroimage Clin; 2017; 13():116-122. PubMed ID: 27942454 [TBL] [Abstract][Full Text] [Related]
4. Invalidation of fMRI experiments secondary to neurovascular uncoupling in patients with cerebrovascular disease. Para AE; Sam K; Poublanc J; Fisher JA; Crawley AP; Mikulis DJ J Magn Reson Imaging; 2017 Nov; 46(5):1448-1455. PubMed ID: 28152241 [TBL] [Abstract][Full Text] [Related]
5. Modeling the impact of neurovascular coupling impairments on BOLD-based functional connectivity at rest. Archila-Meléndez ME; Sorg C; Preibisch C Neuroimage; 2020 Sep; 218():116871. PubMed ID: 32335261 [TBL] [Abstract][Full Text] [Related]
6. A New Functional MRI Approach for Investigating Modulations of Brain Oxygen Metabolism. Griffeth VE; Blockley NP; Simon AB; Buxton RB PLoS One; 2013; 8(6):e68122. PubMed ID: 23826367 [TBL] [Abstract][Full Text] [Related]
7. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease. Yamauchi H; Okazawa H; Kishibe Y; Sugimoto K; Takahashi M Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1349-56. PubMed ID: 12271418 [TBL] [Abstract][Full Text] [Related]
8. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease. Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711 [TBL] [Abstract][Full Text] [Related]
9. White Matter Cerebrovascular Reactivity: Effects of Microangiopathy and Proximal Occlusions on the Dynamic BOLD Response. Gee JM; Wang X; Dogra S; Veraart J; Ishida K; Dehkharghani S medRxiv; 2023 Jun; ():. PubMed ID: 37398412 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET. Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398 [TBL] [Abstract][Full Text] [Related]
11. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease. Okazawa H; Yamauchi H; Sugimoto K; Takahashi M J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179 [TBL] [Abstract][Full Text] [Related]
12. The effect of deafferentation on cerebral blood flow response to acetazolamide. Yamauchi H; Okazawa H; Sugimoto K; Kishibe Y; Takahashi M AJNR Am J Neuroradiol; 2004 Jan; 25(1):92-6. PubMed ID: 14729536 [TBL] [Abstract][Full Text] [Related]
13. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. Chen A; Shyr MH; Chen TY; Lai HY; Lin CC; Yen PS AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859 [TBL] [Abstract][Full Text] [Related]
14. Comparing cerebrovascular reactivity measured using BOLD and cerebral blood flow MRI: The effect of basal vascular tension on vasodilatory and vasoconstrictive reactivity. Halani S; Kwinta JB; Golestani AM; Khatamian YB; Chen JJ Neuroimage; 2015 Apr; 110():110-23. PubMed ID: 25655446 [TBL] [Abstract][Full Text] [Related]
15. A conceptual model for CO₂-induced redistribution of cerebral blood flow with experimental confirmation using BOLD MRI. Sobczyk O; Battisti-Charbonney A; Fierstra J; Mandell DM; Poublanc J; Crawley AP; Mikulis DJ; Duffin J; Fisher JA Neuroimage; 2014 May; 92():56-68. PubMed ID: 24508647 [TBL] [Abstract][Full Text] [Related]
16. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Mandell DM; Han JS; Poublanc J; Crawley AP; Stainsby JA; Fisher JA; Mikulis DJ Stroke; 2008 Jul; 39(7):2021-8. PubMed ID: 18451352 [TBL] [Abstract][Full Text] [Related]
17. Acetazolamide-augmented BOLD MRI to Assess Whole-Brain Cerebrovascular Reactivity in Chronic Steno-occlusive Disease Using Principal Component Analysis. Dogra S; Wang X; Gupta A; Veraart J; Ishida K; Qiu D; Dehkharghani S Radiology; 2023 May; 307(3):e221473. PubMed ID: 36916889 [TBL] [Abstract][Full Text] [Related]
18. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study. Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127 [TBL] [Abstract][Full Text] [Related]
19. The effect of acetazolamide on the changes of cerebral blood flow and oxygen metabolism during visual stimulation. Yamauchi H; Okazawa H; Kishibe Y; Sugimoto K; Takahashi M Neuroimage; 2003 Sep; 20(1):543-9. PubMed ID: 14527614 [TBL] [Abstract][Full Text] [Related]